Home›Stock Screener›Onesource Specialty Pharma

Onesource Specialty Pharma Share Price Today | Stock Price & Onesource Specialty Pharma Share Screener

ONESOURCE Pharmaceuticals
Live Share Price NSE
₹1377.80
▲ 20.70 (1.53%)
2026-10-22 00:00:00
Live Share Price BSE
₹1382.60
▲ 31.40 (2.32%)
2026-10-22 00:00:00

As of October 22, 2026, the live Onesource Specialty Pharma share price (NSE: ONESOURCE) is ₹1,377.80 on NSE and ₹1,382.60 on BSE, up 1.53% from the previous close, with shares trading between ₹1,326.30 and ₹1,385.30 in today's trading session, and a 52-week range of ₹1,114.00–₹1,877.80. Check ONESOURCE annual price range for the annual price range and momentum. Use the Onesource Specialty Pharma stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Onesource Specialty Pharma opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹453 and net income of ₹25, with EBITDA of ₹123, an operating margin of 27.0% and a profit margin of 5.5%.

Onesource Specialty Pharma Market Cap ₹15,671.20 Cr.
ONESOURCE P/E Ratio (TTM) -332.24
Onesource Specialty Pharma P/B Ratio 2.77
EPS (TTM) ₹-6.44
Dividend Yield -
Debt to Equity 0.17
ONESOURCE 52 Week High ₹1877.80
Onesource Specialty Pharma 52 Week Low ₹1114.00
Operating Margin 27.00%
Profit Margin 5.52%
ONESOURCE Revenue (TTM) ₹453.00
EBITDA ₹123.00
Net Income ₹25.00
Total Assets ₹8,210.00
Total Equity ₹5,831.00

Onesource Specialty Pharma Share Price Chart

Track the current stock price of Onesource Specialty Pharma with an interactive chart. Analyse ONESOURCE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Onesource Specialty Pharma stock quote in one place.

The quote of ₹1,377.80 sits between the 52-week low of ₹1,114.00 and the 52-week high of ₹1,877.80, and the latest session moved 1.53% from the previous close.

Onesource Specialty Pharma Company Profile - Fundamental Screener

Screen Onesource Specialty Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ONESOURCE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE013P01021.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE013P01021

Onesource Specialty Pharma Balance Sheet Screener

Screen ONESOURCE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹8,210, up from ₹7,550 in 2025.

Latest statistics put total assets at ₹8,210 and shareholder funds at ₹5,831, with a leverage ratio of 0.17.

Item 2026 2025 2024 2023 2022 2021 2020

Assets

Total Assets 8,210 7,550 1,309 2,009 2,442 1,258 972
Current Assets 0 0 0 0 0 0 0
Fixed Assets 6,017 6,118 863 1,361 1,231 633 354

Liabilities

Total Liabilities 0 0 0 0 0 0 0
Current Liabilities 937 556 282 358 621 321 361
Non-Current Liabilities 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 5,831 5,881 396 786 1,013 776 417
Share Capital 12 11 4 4 3 2 1
Reserves & Surplus 5,819 5,869 392 781 1,009 775 414

Onesource Specialty Pharma Income Statement Screener - Profit & Revenue Analysis

Screen Onesource Specialty Pharma income statement and profit fundamentals. Analyze ONESOURCE quarterly results. Onesource Specialty Pharma reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹453 and net profit was ₹25, equal to earnings per unit of ₹2.18, at an operating margin of 27%.

In that period expenses were ₹330, interest cost ₹31 and tax ₹-5. The next period listed, 2026-Mar, shows revenue of ₹430 and net profit of ₹5.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun

Revenue and Expenses

Revenue 453 430 295 379 333 429 399 338 296 76 88 34 10
Expenses 330 336 280 269 242 244 351 263 233 76 173 105 80

Operating Costs and Margins

EBITDA 123 94 15 110 91 185 48 76 64 0 -85 -71 -70
Operating Profit % 27.00% 21.00% 4.00% 28.00% 26.00% 43.00% 11.00% 21.00% 20.00% -4.00% -207.00% -210.00% -800.00%
Depreciation 72 72 70 70 68 69 69 68 68 20 20 18 19
Interest 31 23 38 34 28 33 46 45 42 21 26 25 18

Profit and Earnings

Profit Before Tax 20 0 -93 6 -4 83 -67 -38 -47 -40 -130 -114 -107
Tax -5 -5 -4 -5 -4 -16 2 5 -41 0 0 0 0
Net Profit 25 5 -89 11 0 99 -69 -42 -6 -40 -130 -114 -107
EPS 2.18 0.40 -7.74 0.92 -0.02 8.61 -6.31 -10.13 -0.51 -9.67 -31.32 -27.37 0.00

Onesource Specialty Pharma Cash Flow Screener - Liquidity Fundamentals

Screen ONESOURCE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹9, and net cash flow was an outflow of ₹127.

Over the same period, investing activities used ₹495 and financing activities provided ₹359.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March

Cash from Operations and Investing

Operating Activities 9 -68 -107 -163 -416 -118
Investing Activities -495 -201 511 -68 -692 -207

Financing and Net Cash

Financing Activities 359 412 -391 118 1,162 381
Net Cash Flow -127 143 13 -112 55 56

Onesource Specialty Pharma Shareholding Pattern Screener

See Onesource Specialty Pharma shareholding pattern with promoter, FII, and DII holdings. Check Onesource Specialty Pharma promoter holding and ownership changes for ONESOURCE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 30.48%, foreign institutions 19.19%, domestic institutions 23.38% and the public 11.29%, spread across 77,899 shareholders.

The shareholder count was 77,899 in 2026-Jun, compared with 79,460 in 2026-Mar.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec

Promoter Holding

Promoter Holding 30.48% 30.48% 29.93% 29.77% 29.79% 34.25% 37.77%

Institutional Investors

FII Holding 19.19% 17.50% 19.24% 19.39% 18.69% 18.54% 17.44%
DII Holding 23.38% 20.61% 18.81% 18.49% 18.10% 18.04% 12.56%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 11.29% 12.18% 12.39% 12.42% 13.25% 12.50% 13.05%
Other Holding 15.65% 19.23% 19.63% 19.93% 20.17% 16.67% 19.18%
Shareholder Count 77,899 79,460 84,595 87,416 87,760 82,712 98,425

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Onesource Specialty Pharma. Onesource Specialty Pharma dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Onesource Specialty Pharma.

Onesource Specialty Pharma Stock Index Membership - Nifty & Sensex

See which indices include Onesource Specialty Pharma stock. Check ONESOURCE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Onesource Specialty Pharma is not part of any tracked indices.
Only major market indices are tracked in our system.

Onesource Specialty Pharma Market Events Screener - Corporate Actions

Get Onesource Specialty Pharma corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Onesource Specialty Pharma stock events that may affect ONESOURCE share price, along with derivatives, futures and options activity and sector gainers.

10 corporate actions are listed, the most recent entry being Annual General Meeting dated September 23, 2026, with a record date of September 23, 2026.

It is followed by Quarterly Result Announcement dated July 24, 2026 and Quarterly Result Announcement dated May 13, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-23 2026-09-23 Annual General Meeting NA 3.55%
2026-07-24 2026-07-24 Quarterly Result Announcement NA 0.20%
2026-05-13 2026-05-13 Quarterly Result Announcement NA 5.21%
2026-01-23 2026-01-23 Quarterly Result Announcement NA -12.34%
2025-11-11 2025-11-11 Quarterly Result Announcement NA -1.91%
2025-09-22 2025-09-22 Annual General Meeting NA -1.03%
2025-08-04 2025-08-04 Quarterly Result Announcement NA -7.38%
2025-05-05 2025-05-05 Quarterly Result Announcement NA -0.05%
2025-01-29 2025-01-29 Quarterly Result Announcement NA -
2024-02-14 2024-02-14 Change Of Name NA -

Onesource Specialty Pharma Competitors Screener - Peer Stocks Comparison

Screen ONESOURCE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 418,204 34.85 61,674 12.69% 11,565 34.47
Divis Laboratories 241,231 83.68 11,067 13.95% 2,568 45.19
Torrent Pharmaceuticals 173,398 80.45 13,886 20.34% 2,138 32.75
Laurus Labs 111,791 102.03 6,868 22.01% 890 61.47
Zydus Life Science 111,112 24.42 27,658 17.64% 5,026 42.73
Cipla 106,969 31.90 29,045 2.24% 3,870 40.05
Dr Reddys Laboratories 103,709 32.30 35,059 3.90% 4,158 59.92
Aurobindo Pharma 93,292 25.74 34,145 5.56% 3,503 40.47
Mankind Pharma 93,067 45.45 14,636 14.85% 1,938 36.17
Lupin 88,678 16.11 29,039 26.75% 5,356 32.65

Onesource Specialty Pharma Company Announcements - News & Reports Screener

Screen ONESOURCE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 25, 2026.

The next most recent announcements are dated September 25, 2026 and September 25, 2026.

Date Update Actions
2026-09-25 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-09-25 Closure of Trading Window -
2026-09-25 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-23 Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s -
2026-09-23 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-11 General Update -
2026-09-03 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-01 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-31 Notice Of The 19Th AGM Dated September 23 2026 -
2026-08-31 Business Responsibility and Sustainability Reporting (BRSR) -
2026-08-31 Reg. 34 (1) Annual Report. -
2026-08-31 Reg. 34 (1) Annual Report. -
2026-08-31 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-29 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-18 Announcement under Regulation 30 (LODR)-Credit Rating -
2026-07-31 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-07-27 Announcement under Regulation 30 (LODR)-Change in Management -
2026-07-26 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-25 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-07-24 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹1,377.80, within a 52-week range of ₹1,114.00 to ₹1,877.80. The P/E ratio is -332.24 and the P/B ratio is 2.77, with earnings per unit of ₹-6.44. Market capitalisation stands at ₹15,671.20 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 24, 2026. This page covers 7 balance sheet periods, 13 income statement periods, 6 cash flow years and 7 shareholding periods. Information is provided for research and is not investment advice.